What is the correct sig and number of patches to prescribe for the initial dose of Climara (estradiol) 0.0375 mg transdermal patch applied once weekly?

Climara 0.0375 mg Weekly Patch Prescription

For initial dosing of Climara 0.0375 mg transdermal patch applied once weekly, prescribe 4 patches for a 1-month supply.

Prescription Sig

"Apply one patch to lower abdomen once weekly. Change patch every 7 days. Rotate application sites."

Rationale for Quantity

The Climara patch is designed for 7-day continuous wear 1. Each patch is worn for one full week before replacement, requiring:

• 4 patches per 28-day cycle (standard monthly supply)
• 13 patches per 3-month supply (if prescribing quarterly)

Detailed Application Instructions

Site Selection & Application

• Apply to smooth, clean, dry skin on the lower abdomen 1
• Avoid the waistline (tight clothing can dislodge the patch) 1
• Do not apply to or near breasts 1
• Rotate application sites with at least 1 week between applications to the same site 1

Application Technique

1. Remove one side of protective liner without touching adhesive
2. Apply immediately to skin
3. Remove second side of liner
4. Press firmly for at least 10 seconds, ensuring good edge contact 1

Patch Management

• One patch worn continuously for 7 days before replacement 1
• If patch falls off, reapply the same patch or apply a new one and continue original schedule 1
• Only one patch should be worn at any time 1
• Avoid prolonged sun exposure to patch site 1

Important Clinical Considerations

Progestin Requirement

If the patient has an intact uterus, you must also prescribe a progestin to reduce endometrial cancer risk 1. The 0.0375 mg Climara patch contains estradiol only. Consider:

• Oral micronized progesterone 200 mg for 12-14 days every 28 days 2
• Medroxyprogesterone acetate 10 mg for 12-14 days per month 2
• Alternatively, use Climara Pro (combined estradiol/levonorgestrel patch) if available 1

Dose Considerations

The 0.0375 mg dose is below the typical starting dose recommended in most guidelines. Standard transdermal estradiol dosing typically starts at 50-100 μg daily (0.05-0.1 mg/day) 2, 3. The 0.0375 mg dose may be appropriate for:

• Very estrogen-sensitive patients
• Those requiring minimal symptom control
• Gradual dose escalation strategies

Be prepared to titrate upward if symptoms are inadequately controlled 3, 1. The FDA label states "the lowest effective dose of Climara Pro has not been determined" 1, and clinical response should guide dosing.

Monitoring & Follow-up

• Re-evaluate at 3-6 month intervals to determine if treatment remains necessary 1
• Titrate dose based on symptom response and tolerability 3
• For patients with persistent symptoms despite dose escalation, consider measuring serum estradiol levels 3

Common Pitfalls

• Application site reactions occur in approximately 40% of patients 1 but lead to discontinuation in only 2-8% 1, 4
• Adhesion is generally excellent with 7-day patches, with >94% remaining in place 5
• Buttock application may increase absorption by 17% compared to abdomen 6, which could benefit patients with end-of-week symptom breakthrough